Istituto Auxologico Italiano, IRCCS, Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Hypertens Res. 2020 Jul;43(7):621-628. doi: 10.1038/s41440-020-0422-4. Epub 2020 Mar 18.
Due to fast-paced technological advancements, digital health and telemedicine represent a promising and complex reality, with the potential to change the current management of hypertension and improve its outcomes. New types of health-related strategies are available, ranging from telemonitoring of blood pressure (BP) values to counseling for patients and decisional tools for physicians, thanks to the development of new technology. Even though the strength of available evidence is currently low due to the high heterogeneity of studies and of the proposed interventions, available data suggest a beneficial effect of digital health strategies on BP control and, more generally, on cardiovascular risk reduction. In addition, well-designed randomized controlled trials are needed to further investigate the real impact of these new strategies on clinical outcomes. Furthermore, due to consistent commercial interests in this field, there is a strong need for strict regulations to ensure a safe and secure implementation of this new reality in clinical care.
由于技术的快速发展,数字医疗和远程医疗代表了一个充满希望但又复杂的现实,它们有可能改变目前高血压的管理方式并改善其预后。新的健康相关策略层出不穷,从远程血压监测到对患者的咨询,再到为医生提供决策工具,这都要归功于新技术的发展。尽管由于研究和所提出的干预措施的高度异质性,目前可用证据的强度较低,但现有数据表明数字医疗策略对血压控制,以及更广泛的心血管风险降低有有益的影响。此外,还需要精心设计的随机对照试验来进一步研究这些新策略对临床结局的实际影响。此外,由于该领域存在一致的商业利益,因此强烈需要严格的监管,以确保在临床护理中安全可靠地实施这一新现实。